
Phio Pharmaceuticals Corp.
PHIONasdaqCIK 1533040HealthcareFiscal year ends Dec 31
Reports and events: 316 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-12-1908:38 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-24-008833 |
| 2024-11-1416:49 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001683168-24-008120 |
| 2024-11-1416:47 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-24-008118 |
| 2024-11-0710:21 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-24-007713 |
| 2024-08-1417:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-24-005707 |
| 2024-08-1416:45 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001683168-24-005706 |
| 2024-08-0108:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001683168-24-005194 |
| 2024-07-2616:30 ET | S-1 | Registration statement | 0001683168-24-005092 |
| 2024-07-2416:30 ET | 8-K | 8.01 Other events | 0001683168-24-005049 |
| 2024-07-1216:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-24-004800 |
| 2024-07-0508:01 ET | 8-K | 1.02 Termination of a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-24-004683 |
| 2024-07-0217:00 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-24-004619 |
| 2024-06-2116:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001683168-24-004417 |
| 2024-05-2817:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-24-003849 |
| 2024-05-1716:45 ET | S-1 | Registration statement | 0001683168-24-003624 |
| 2024-05-1709:00 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-24-003598 |
| 2024-05-0917:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-24-003178 |
| 2024-05-0917:20 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001683168-24-003175 |
| 2024-05-0817:02 ET | DEF 14A | Proxy statementPeriod 2024-06-17 | 0001683168-24-003113 |
| 2024-04-0207:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-24-002050 |
| 2024-04-0116:31 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001683168-24-002021 |
| 2024-01-2617:00 ET | 8-K | 3.01 Delisting notice | 0001683168-24-000489 |
| 2023-12-1916:52 ET | S-1 | Registration statement | 0001683168-23-008964 |
| 2023-12-0817:00 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-23-008732 |
| 2023-11-0916:40 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-23-007815 |
| 2023-11-0916:31 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001683168-23-007809 |
| 2023-08-2107:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-23-005923 |
| 2023-08-1016:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-23-005515 |
| 2023-08-1016:30 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001683168-23-005514 |
| 2023-07-2616:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001683168-23-005094 |
| 2023-06-0916:30 ET | DEF 14A | Proxy statementPeriod 2023-07-20 | 0001683168-23-004045 |
| 2023-06-0817:00 ET | S-1 | Registration statement | 0001683168-23-004016 |
| 2023-06-0216:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-23-003863 |
| 2023-05-2407:35 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-23-003671 |
| 2023-05-1607:35 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-23-003433 |
| 2023-05-1117:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-23-003214 |
| 2023-05-1117:01 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001683168-23-003213 |
| 2023-04-2817:07 ET | S-1 | Registration statement | 0001683168-23-002765 |
| 2023-04-2017:22 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-23-002559 |
| 2023-04-2014:53 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001683168-23-002542 |
| 2023-04-1807:55 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-23-002493 |
| 2023-04-1717:25 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-23-002488 |
| 2023-03-2217:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001683168-23-001679 |
| 2023-03-2217:00 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001683168-23-001678 |
| 2023-03-1017:10 ET | 8-K | 8.01 Other events | 0001683168-23-001424 |
| 2023-02-2207:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001683168-23-001075 |
| 2023-02-1307:30 ET | 8-K | 8.01 Other events | 0001683168-23-000781 |
| 2023-01-2508:35 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-23-000307 |
| 2023-01-0617:00 ET | 8-K | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001683168-23-000098 |
| 2022-12-2116:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001683168-22-008584 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 20:44 ET. Listed shows no prices and gives no investment advice.